AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROCKET PHARMACEUTICALS, INC. Director's Dealing 2020

Jun 19, 2020

33148_dirs_2020-06-18_b950e45f-1b2d-41ed-aa04-8511a6786b77.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2020-06-16

Reporting Person: WONG RODERICK (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-16	Stock Option (Right to Buy)	$19.9	A	27000	Acquired	2030-06-16	Common Stock (27000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 27,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021.